Restart Life Sciences Corp. (CSE: HEAL)

Canada flag Canada · Delayed Price · Currency is CAD
0.0450
+0.0050 (12.50%)
Nov 20, 2024, 9:30 AM EST
-70.00%
Market Cap 1.19M
Revenue (ttm) n/a
Net Income (ttm) -628.58K
Shares Out 29.66M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,000
Open 0.0450
Previous Close 0.0400
Day's Range 0.0450 - 0.0450
52-Week Range 0.0150 - 0.1500
Beta 0.63
Analysts n/a
Price Target n/a
Earnings Date Nov 27, 2024

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing diagnostics and psilocybin-based therapeutics for the treatment of neuroinflammatory disorders, including autism spectrum disorder and fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2004
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol HEAL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.